News

Stay up to date with the latest activity at Richmond Pharmacology

Making gains in drug development

2
September 2021

Keith Berelowitz outlines the innovations in the design and delivery of clinical trials

View article

Inclisirin hailed as a 'gamechanger' gains approval for NHS patients

2
September 2021

This novel therapeutic drug has potential to impact millions at risk of heart attack and stroke.

View article

Richmond Pharmacology listed in the Alantra Pharma Fast 50

13
July 2021

Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 

View article

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

29
June 2021

Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.

View article

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

29
June 2021

J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.

View article

What 20 years of clinical research has taught us about our industry and the future of drug development

9
June 2021

As Richmond Pharmacology approaches its 20th anniversary our co-founder and CEO reflects on the developments, regulatory changes, and innovations within the life science industry in an article in the PharmaTimes.

View article

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Making gains in drug development

September 2, 2021
Keith Berelowitz outlines the innovations in the design and delivery of clinical trials
Read more

Inclisirin hailed as a 'gamechanger' gains approval for NHS patients

September 2, 2021
This novel therapeutic drug has potential to impact millions at risk of heart attack and stroke.
Read more

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more